Revisiting our "Call of the Week”

[] Insider buying is an important anomaly in the stock market. Today, Garrett is breaking down the movement of a stock called ORIC Pharmaceuticals and why the insider is buying the stock. [View in browser]( . Insider buying is an important anomaly in the stock market. Today, Garrett is breaking down the movement of a stock called ORIC Pharmaceuticals and why the insider is buying the stock. [View in browser]( . . [] [Havens Investment Letter] [] [Havens Investment Letter] [] [] [] 2-Decade Trading Veteran: I want as many people as possible to know about this Legendary trader Rob Booker is on to something. Why are newsletters so popular... when you have to wait a month to receive stock picks? He’s found the solution that the big-wigs will never tell you. [See this and never wait for a monthly stock pick again.]( [] --------------------------------------------------------------- [] 2-Decade Trading Veteran: I want as many people as possible to know about this Legendary trader Rob Booker is on to something. Why are newsletters so popular... when you have to wait a month to receive stock picks? He’s found the solution that the big-wigs will never tell you. [See this and never wait for a monthly stock pick again.]( [] --------------------------------------------------------------- [] [] Revisiting our “Call of the Week” Dear Investor, On Monday, I sent you this chart. [Top Stocks]( I noted that the Oric Pharmaceuticals (ORIC) CEO bought 350,000 shares at an average of $4.92 on March 23. On Monday, shares rallied more than 16% on the news. We like to snap up shares when combining biotech stocks with CEO/CFO buying and event-driven catalysts. We want to hold for 30 days… and wait to find the catalyst. On Tuesday, the stock kept climbing as I talked about why we like insider buying… Did you buy the stock? Because we found our catalyst. Today, shares rallied 23.6% after news broke that the CFO bought shares last night, and the company made a significant announcement about its trial plans. We knew that the company planned to present clinical research during an upcoming investment conference. But the big news today was that it was scrapping a drug trial that helped launch its IPO. So after shares plunged from $25 to $5 in six months… [ORIC] The insiders were loading up. And this was the result after the CEO bought the stock… [ORIC] I think it’s very critical to buy when there is CFO/CEO insider buying plus a catalyst within the next 30 days. We’ll continue to talk about these trades as they emerge. Stay patient. Now What for the Markets Today was an awful day for the markets. Now - you might sign onto CNBC and see this… It looks like the markets rallied, right? That we had a nice gain after Thursday’s selloff. [Indicies]( I don’t see those numbers when I look at the markets. Look below… I see this - a weight of momentum for each sector in the market. [Sectors] This array of colors signals a problematic combination. Consumer cyclical, financials, industrials, and technology stocks are experiencing an undercurrent of selling. Today, retail stores, regional banks, transportation (rail), and semiconductors looked bad. What is that? It’s the economy. I’m seeing institutional capital selling off stocks due to the inversion of the yield curve, an early warning of a possible recession. That combination should not be ignored. Broader market momentum is positive. But I feel like the last two-week is a little too extended. The recent profit-taking was something, and my concern is that our day in the sun - or, as I said, “eye of the storm” - might be coming to a close quickly. A Possible Catalyst Next week, I want you to sit by your computer and watch one chart. Watch what happens to the QQQ at 2 pm on Wednesday. During this hour on this day, the Federal Reserve will release minutes from its March meeting. We all witnessed a massive reversal on March 16 after Fed Chair Jerome Powell denied that a recession would happen in the U.S. economy in the months ahead. But this inversion of the bond curve has changed the calculus. My question - is, just how much? The essential news from the minutes will be the timing of the Fed’s balance sheet tapering. Will there be any updates? Will we have a timeline? The key story of the March meeting was the number of times that the central bank would raise interest rates this year to tackle inflation. But the Fed still sits on a $9 trillion balance sheet that it needs to unwind. So the Fed will need to sell these assets back into the market, which could have a dramatic impact. The last time that the Fed tapered its balance sheet, the S&P 500 fell more than 6% in 2018. I won’t be thinking about it all too much this weekend. I’m taking my daughter to her first baseball game, and I’m looking forward to it. Of course, it’s Spring Training, but it will do… Go Orioles… Enjoy your weekend, [Garrett Sig] Garrett {NAME} Chief Analyst, American Markets [] --------------------------------------------------------------- [] [] Revisiting our “Call of the Week” Dear Investor, On Monday, I sent you this chart. [Top Stocks]( I noted that the Oric Pharmaceuticals (ORIC) CEO bought 350,000 shares at an average of $4.92 on March 23. On Monday, shares rallied more than 16% on the news. We like to snap up shares when combining biotech stocks with CEO/CFO buying and event-driven catalysts. We want to hold for 30 days… and wait to find the catalyst. On Tuesday, the stock kept climbing as I talked about why we like insider buying… Did you buy the stock? Because we found our catalyst. Today, shares rallied 23.6% after news broke that the CFO bought shares last night, and the company made a significant announcement about its trial plans. We knew that the company planned to present clinical research during an upcoming investment conference. But the big news today was that it was scrapping a drug trial that helped launch its IPO. So after shares plunged from $25 to $5 in six months… [ORIC] The insiders were loading up. And this was the result after the CEO bought the stock… [ORIC] I think it’s very critical to buy when there is CFO/CEO insider buying plus a catalyst within the next 30 days. We’ll continue to talk about these trades as they emerge. Stay patient. Now What for the Markets Today was an awful day for the markets. Now - you might sign onto CNBC and see this… It looks like the markets rallied, right? That we had a nice gain after Thursday’s selloff. [Indicies]( I don’t see those numbers when I look at the markets. Look below… I see this - a weight of momentum for each sector in the market. [Sectors] This array of colors signals a problematic combination. Consumer cyclical, financials, industrials, and technology stocks are experiencing an undercurrent of selling. Today, retail stores, regional banks, transportation (rail), and semiconductors looked bad. What is that? It’s the economy. I’m seeing institutional capital selling off stocks due to the inversion of the yield curve, an early warning of a possible recession. That combination should not be ignored. Broader market momentum is positive. But I feel like the last two-week is a little too extended. The recent profit-taking was something, and my concern is that our day in the sun - or, as I said, “eye of the storm” - might be coming to a close quickly. A Possible Catalyst Next week, I want you to sit by your computer and watch one chart. Watch what happens to the QQQ at 2 pm on Wednesday. During this hour on this day, the Federal Reserve will release minutes from its March meeting. We all witnessed a massive reversal on March 16 after Fed Chair Jerome Powell denied that a recession would happen in the U.S. economy in the months ahead. But this inversion of the bond curve has changed the calculus. My question - is, just how much? The essential news from the minutes will be the timing of the Fed’s balance sheet tapering. Will there be any updates? Will we have a timeline? The key story of the March meeting was the number of times that the central bank would raise interest rates this year to tackle inflation. But the Fed still sits on a $9 trillion balance sheet that it needs to unwind. So the Fed will need to sell these assets back into the market, which could have a dramatic impact. The last time that the Fed tapered its balance sheet, the S&P 500 fell more than 6% in 2018. I won’t be thinking about it all too much this weekend. I’m taking my daughter to her first baseball game, and I’m looking forward to it. Of course, it’s Spring Training, but it will do… Go Orioles… Enjoy your weekend, [Garrett Sig] Garrett {NAME} Chief Analyst, American Markets --------------------------------------------------------------- [] Reclusive California Tech Wiz Reveals... the Perfect AAPL Trade [San Francisco bay]( [See the reveal of this remarkable system]( --------------------------------------------------------------- [] [] Reclusive California Tech Wiz Reveals... the Perfect AAPL Trade [San Francisco bay]( [See the reveal of this remarkable system]( --------------------------------------------------------------- [] [] [] [Recommended] Daily List Of High-Probability Stock Trades Every morning, before the market even opens, this pro trader sends out a list of his top high-potential stock picks for the day… And [open enrollment is still available to the public.]( “Stocks with the highest probabilities of moving 5% to 10% in just a couple of hours each trading day.” Tired of wasting time (and cash) looking for “perfect” stock trade setups that always seem to… lose money the minute you enter the trade… move sideways or don’t even move at all… or pump and dump before you can even enter the “buy” button? Let a seasoned trading pro with DECADES of trading success hand select your daily trades for you! Just like trading “side-by-side” with a real professional trader, you’ll get a chance to… “…make $490 (or more) every single day the market is open.” That’s a potential $98,000 a year in trading profits just by simply following along and placing the exact same stocks as a real veteran trader. [>>CLICK HERE TO SIGN UP FOR THE LIST]( --------------------------------------------------------------- [] [] [] [Recommended] Daily List Of High-Probability Stock Trades Every morning, before the market even opens, this pro trader sends out a list of his top high-potential stock picks for the day… And [open enrollment is still available to the public.]( “Stocks with the highest probabilities of moving 5% to 10% in just a couple of hours each trading day.” Tired of wasting time (and cash) looking for “perfect” stock trade setups that always seem to… lose money the minute you enter the trade… move sideways or don’t even move at all… or pump and dump before you can even enter the “buy” button? Let a seasoned trading pro with DECADES of trading success hand select your daily trades for you! Just like trading “side-by-side” with a real professional trader, you’ll get a chance to… “…make $490 (or more) every single day the market is open.” That’s a potential $98,000 a year in trading profits just by simply following along and placing the exact same stocks as a real veteran trader. [>>CLICK HERE TO SIGN UP FOR THE LIST]( --------------------------------------------------------------- [] [] Article Recap - [Revisiting our “Call of the Week”](#i572731) - [[Recommended] Daily List Of High-Probability Stock Trades](#156391) --------------------------------------------------------------- [] Article Recap - [Revisiting our “Call of the Week”](#i572731) - [[Recommended] Daily List Of High-Probability Stock Trades](#156391) --------------------------------------------------------------- [] © 2022 Godesburg Financial Publishing, Inc. DISCLAIMER: COMMUNICATIONS FROM GODESBURG FINANCIAL PUBLISHING (GFP) ARE FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY – NOT INVESTMENT ADVICE: GFP and all the services it offers are for educational and informational purposes only and should NOT be understood to be securities-related offers or solicitations. None of GFP’s communications should be considered or used as personalized investment advice. GFP recommends that you speak with a licensed professional before making any investment decision. RESULTS PRESENTED ARE NOT NECCESSARILY TYPICAL OR VERIFIED: GFP communications may include information regarding the historical trading performance of gurus in their services (all verified by a third party), as well as testimonials of non-employees depicting profitable investments and trades that are believed to be true based on the representations of the persons providing the testimonial of their own free will. Please be aware that the claims regarding investing or trading results of non-employees are not tracked by GFP nor can they be verified. As always, past performance is not necessarily indicative of future results. Therefore, results presented in this email should NOT be considered TYPICAL. Actual results can and will vary based on everything from experience, ability, risk mitigation practices, and market volatility... to the amount of money exposed in the investment or trade. Investing and trading are speculative and carry serious risk. You may lose some, all - or possibly more - than your original investment or trade. GODESBURG FINANCIAL PUBLISHING IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER: GFP, including its owners and employees, are NOT registered as securities broker-dealers, brokers, or any sort of registered investment advisors with the U.S. Securities and Exchange Commission, any state securities regulatory authorities, or any self-regulatory organizations. GODESBURG FINANCIAL PUBLISHING EMPLOYEES MAY HOLD SECURITIES DISCUSSED: If a writer holds any securities in a communication, it will be disclosed along with the information on the potential investment or trade. HIR, its owners or employees, have not been - or ever will be - paid by the issuer of a security mentioned in our services or communications. GFP, its owners and employees are paid entirely or in part from commissions based on sales of their services to subscribers. For more information, please visit [our disclaimer page here.]( Sent to: {EMAIL} [Unsubscribe]( Godesburg Financial Publishing Inc., 251 Little Falls Drive, Wilmington, DE 19808, United States [] © 2022 Godesburg Financial Publishing, Inc. DISCLAIMER: COMMUNICATIONS FROM GODESBURG FINANCIAL PUBLISHING (GFP) ARE FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY – NOT INVESTMENT ADVICE: GFP and all the services it offers are for educational and informational purposes only and should NOT be understood to be securities-related offers or solicitations. None of GFP’s communications should be considered or used as personalized investment advice. GFP recommends that you speak with a licensed professional before making any investment decision. RESULTS PRESENTED ARE NOT NECCESSARILY TYPICAL OR VERIFIED: GFP communications may include information regarding the historical trading performance of gurus in their services (all verified by a third party), as well as testimonials of non-employees depicting profitable investments and trades that are believed to be true based on the representations of the persons providing the testimonial of their own free will. Please be aware that the claims regarding investing or trading results of non-employees are not tracked by GFP nor can they be verified. As always, past performance is not necessarily indicative of future results. Therefore, results presented in this email should NOT be considered TYPICAL. Actual results can and will vary based on everything from experience, ability, risk mitigation practices, and market volatility... to the amount of money exposed in the investment or trade. Investing and trading are speculative and carry serious risk. You may lose some, all - or possibly more - than your original investment or trade. GODESBURG FINANCIAL PUBLISHING IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER: GFP, including its owners and employees, are NOT registered as securities broker-dealers, brokers, or any sort of registered investment advisors with the U.S. Securities and Exchange Commission, any state securities regulatory authorities, or any self-regulatory organizations. GODESBURG FINANCIAL PUBLISHING EMPLOYEES MAY HOLD SECURITIES DISCUSSED: If a writer holds any securities in a communication, it will be disclosed along with the information on the potential investment or trade. HIR, its owners or employees, have not been - or ever will be - paid by the issuer of a security mentioned in our services or communications. GFP, its owners and employees are paid entirely or in part from commissions based on sales of their services to subscribers. For more information, please visit [our disclaimer page here.]( Sent to: {EMAIL} [Unsubscribe]( Godesburg Financial Publishing Inc., 251 Little Falls Drive, Wilmington, DE 19808, United States